This poster was originally authored by John Vincent, Matthew Burnham, Gerrit Daubner, and Martin Main of the Medicines Discovery Catapult. It was presented at ELRIG Drug Discovery 2023. Methods to ...

To permanently access this App Note for free, fill out the short form below. UVA-excited dyes on qTOWER iris qPCR platforms enable sensitive thermal shift assays for challenging hydrophobic and ...

Swedish chemist Jöns Jacob Berzelius, in a letter to a fellow chemist, first suggested the name ‘proteins’ for a particular class of biological substances, deriving it from the Greek word proteios, ...

This article and associated images are based on a poster originally authored by Paulina Chorobik, Maciej B. Olszewski, John Vincent and Kirsty Winn and presented at ELRIG Drug Discovery 2025 in ...

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

Merck KGaA's subsidiary MilliporeSigma has developed a first-of-its-kind “all-in-one” CHO genetic stability assay, according to an April 16 release. The company claims that the platform, called ...

As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Germany, says it has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra™ CHO genetic ...

Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by ...

This webinar examines practical approaches to strengthening lateral flow assay performance, with a focus on optimized sample ...